Skip to main content
SpringerLink
Log in

Antiglycan Antibodies in Greek Patients with Inflammatory Bowel Disease

  • Original Article
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Background

Antiglycan antibodies have recently been reported to be associated with Crohn’s disease (CD). These antibodies include anti-Saccharomyces cerevisiae mannan antibodies (ASCA), anti-laminariobioside carbohydrate antibodies (ALCA), anti-chitobioside carbohydrate antibodies (ACCA), and anti-mannobioside carbohydrate antibodies (AMCA).

Aims

The aim of this study was to evaluate their diagnostic accuracy in Greek patients with inflammatory bowel disease (IBD).

Methods

Serum was collected from 191 patients with IBD (85 with ulcerative colitis (UC) and 106 with CD), 29 cases with other causes of intestinal inflammation and 96 healthy controls. Antiglycan antibodies were measured using commercially available enzyme immunoassays.

Results

Higher levels of antiglycan antibodies were detected in patients with CD compared to patients with UC and controls. Although all types of antiglycan antibodies had a high specificity for diagnosing CD, their sensitivity was rather low, with best results obtained with ASCA and ALCA (41.5 and 52.8%, respectively). Increased levels of ASCA and ALCA were associated with stricturing and penetrating disease phenotype, and the need for surgery (p < 0.05).

Conclusions

Antiglycan antibodies in Greek IBD patients are significantly associated with CD, and especially to phenotypes of complicated disease, with ASCA and ALCA exhibiting the highest sensitivity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Quinton JF, Sendid B, Reumaux D, et al. Anti- Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role. Gut. 1998;42:788–791.

    Article  CAS  PubMed  Google Scholar 

  2. Peeters M, Joossens S, Vermeire S, Vlietinck R, Bossuyt X, Rutgeerts P. Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease. Am J Gastroenterol. 2001;96:730–734.

    Article  CAS  PubMed  Google Scholar 

  3. Sandborn WJ, Loftus EV Jr, Colombel JF, et al. Evaluation of serologic disease markers in a population-based cohort of patients with ulcerative colitis and Crohn’s disease. Inflamm Bowel Dis. 2001;7:192–201.

    Article  CAS  PubMed  Google Scholar 

  4. Koutroubakis IE, Petinaki E, Mouzas IA, et al. Anti Saccharomyces cerevisiae mannan antibodies and antineutrophil cytoplasmic autoantibodies in Greek patients with inflammatory bowel disease. Am J Gastroenterol. 2001;96:449–454.

    CAS  PubMed  Google Scholar 

  5. Zholudev A, Zurakowski D, Young W, Leichtner A, Bousvaros A. Serologic testing with ANCA, ASCA, and anti-OmpC in children and young adults with Crohn’s disease and ulcerative colitis: diagnostic value and correlation with disease phenotype. Am J Gastroenterol. 2004;99:2235–2241.

    Article  PubMed  Google Scholar 

  6. Mow WS, Vasiliauskas EA, Lin YC, et al. Association of antibody responses to microbial antigens and complications of small bowel Crohn’s disease. Gastroenterology. 2004;126:414–424.

    Article  CAS  PubMed  Google Scholar 

  7. Targan SR, Landers CJ, Yang H, et al. Antibodies to CBir1 flagellin define a unique response that is associated independently with complicated Crohn’s disease. Gastroenterology. 2005;128:2020–2028.

    Article  CAS  PubMed  Google Scholar 

  8. Dubinsky MC, Lin YC, Dutridge D, et al. Serum immune responses predict rapid disease progression among children with Crohn’s disease: immune responses predict disease progression. Am J Gastroenterol. 2006;101:360–367.

    Article  PubMed  Google Scholar 

  9. Dotan I, Fishman S, Dgani Y, et al. Antibodies against laminaribioside and chitobioside are novel serologic markers in Crohn’s disease. Gastroenterology. 2006;131:366–378.

    Article  CAS  PubMed  Google Scholar 

  10. Li X, Conklin L, Alex P. New serological biomarkers of inflammatory bowel disease. World J Gastroenterol. 2008;14:5115–5124.

    Article  CAS  PubMed  Google Scholar 

  11. Ferrante M, Henckaerts L, Joossens M, et al. New serological markers in inflammatory bowel disease are associated with complicated disease behaviour. Gut. 2007;56:1394–1403.

    Article  PubMed  Google Scholar 

  12. Papp M, Altorjay I, Dotan N, et al. New serological markers for inflammatory bowel disease are associated with earlier age at onset, complicated disease behavior, risk for surgery, and NOD2/CARD15 genotype in a Hungarian IBD cohort. Am J Gastroenterol. 2008;103:665–681.

    Article  CAS  PubMed  Google Scholar 

  13. Simondi D, Mengozzi G, Betteto S, et al. Antiglycan antibodies as serological markers in the differential diagnosis of inflammatory bowel disease. Inflamm Bowel Dis. 2008;14:645–651.

    Article  PubMed  Google Scholar 

  14. Rieder F, Schleder S, Wolf A, et al. Association of the novel serologic anti-glycan antibodies anti-laminarin and anti-chitin with complicated Crohn’s disease behavior. Inflamm Bowel Dis. 2010;16:263–274.

    Article  PubMed  Google Scholar 

  15. Stange EF, Travis SPL, Vermeire S, et al. European Crohn’s and Colitis Organisation. European evidence based consensus on the diagnosis and management of Crohn’s disease: definitions and diagnosis. Gut. 2006;55:1–15.

    Article  Google Scholar 

  16. Silverberg MS, Satsangi J, Ahmad T, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol. 2005;19(Suppl A):5–36.

    PubMed  Google Scholar 

  17. Best WR, Becktel JM, Singleton JW, Kern F Jr. Development of a Crohn’s disease activity index. National Cooperative Crohn’s Disease Study. Gastroenterology. 1976;70:439–444.

    CAS  PubMed  Google Scholar 

  18. Walmsley RS, Ayres RC, Pounder RE, Allan RN. A simple clinical colitis activity index. Gut. 1998;43:29–32.

    Article  CAS  PubMed  Google Scholar 

  19. Dotan N, Altstock RT, Schwarz M, Dukler A. Anti-glycan antibodies as biomarkers for diagnosis and prognosis. Lupus. 2006;15:442–450.

    Article  CAS  PubMed  Google Scholar 

  20. Rieder F, Schleder S, Wolf A, et al. Serum anti-glycan antibodies predict complicated Crohn’s disease behavior: A cohort study. Inflamm Bowel Dis. 2010 [Epub ahead of print] PMID: 20024902.

  21. Joossens M, Van Steen K, Branche J, et al. Familial aggregation and antimicrobial response dose-dependently affect the risk for Crohn’s disease. Inflamm Bowel Dis. 2010;16:58–67.

    PubMed  Google Scholar 

  22. Joossens S, Reinisch W, Vermeire S, et al. The value of serologic markers in indeterminate colitis: a prospective follow-up study. Gastroenterology. 2002;122:1242–1247.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Gastroenterology, University Hospital Heraklion, PO Box 1352, 71110, Heraklion, Crete, Greece

    Ioannis E. Koutroubakis, Pantelis Oustamanolakis, Konstantinos Karmiris & Elias A. Kouroumalis

  2. Laboratory of Immunology General Hospital of Rethymnon, Heraklion, Greece

    Dimitrios Drygiannakis

  3. Department of Immunology-Histocompatibility, Evangelismos Hospital Athens, Athens, Greece

    Alexandra Tsirogianni

  4. 1st Department of Gastroenterology, Evangelismos Hospital Athens, Athens, Greece

    Konstantinos Papamichael & Gerassimos J. Mantzaris

Authors
  1. Ioannis E. Koutroubakis
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Dimitrios Drygiannakis
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Alexandra Tsirogianni
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Pantelis Oustamanolakis
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Konstantinos Karmiris
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Konstantinos Papamichael
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Gerassimos J. Mantzaris
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Elias A. Kouroumalis
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ioannis E. Koutroubakis.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Koutroubakis, I.E., Drygiannakis, D., Tsirogianni, A. et al. Antiglycan Antibodies in Greek Patients with Inflammatory Bowel Disease. Dig Dis Sci 56, 845–852 (2011). https://doi.org/10.1007/s10620-010-1328-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-010-1328-9

Keywords

Search

Navigation